CAS: 1722-18-5; 2-Phenyl-1,3,5-Triazine

该化合物是一个有机化合物,其特征是三氮环结构,由三个氮原子和三个碳原子组成,由六人组成的芳香环组成,其特征是连接于三亚胺环碳原子中的一组苯基,有助于其芳香特性;苯基-1-35-三亚胺通常是晶体固体,在标准条件下具有稳定性;众所周知,它在各个领域,包括材料科学和有机合成,特别是在染料和农用化学的开发方面的潜在应用;三亚胺环中存在的氮具有独特的电子特性,使其在与电子材料和光化学有关的研究中成为一个主题;此外,其溶性特征可能因溶剂而异,影响其再活性和与其他化学物种的相互作用;

结构式图片

上下游产品

1,3,5-Triazine benzamidine monohydr°Chloride benzamidin 2,4-bis(methylthio)-6-phenyl-1,3,5-triazine

合成工艺路线路线简述

    📜2,4-Bis(Methylthio)-6-Phenyl-1,3,5-Triazine置于1,4-二氧六环,镍体系中,化学反应生成苯基-1,3,5-三嗪
    参考文献:Grundmann Et Al.,Chemische Berichte,1953,Vol. 86,P. 181,184
    标题:Grundmann Et Al.,Chemische Berichte,1953,Vol. 86,P. 181,184

    海关参考信息

    专利信息


    专利号:US-8329923-B2
    优先权日:2010-06-17
    标 题:4, 4′ disubstituted 4H-cyclopentadithiophene and new methods for synthesizing the same
    发明人:VANDERZANDE DIRK; LUTSEN LAURENCE; VAN MIERLOO SARAH
    权利人:VANDERZANDE DIRK; LUTSEN LAURENCE; VAN MIERLOO SARAH; IMEC; UNIV HASSELT
    摘要:The present preferred embodiments relate to a method for the synthesis of a compound having the following general formula: n nthe method comprising the step of reacting, in presence of a diprotic acid having a negative pKa, a compound having the general formula:n n nwherein R 1 and R 2 are organic groups and wherein X and Y are independently selected from the group consisting of hydrogen, chloro, bromo, iodo, boronic acid, boronate esters, borane, pseudohalogen and organotin. It further relates to compounds so obtained and to compounds resulting from the ring closure of compound (II).

    专利号:US-7687635-B2
    优先权日:2002-01-22
    标 题:Metal complexes useful in metathesis and other reactions
    发明人:VERPOORT FRANCIS WALTER CORNELIUS; DE CLERCQ BOB
    权利人:TELENE S A S
    摘要:This invention provides metal complexes being useful as catalyst components in metathesis reactions and in reactions involving the transfer of an atom or group to an ethylenically or acetylenically unsaturated compound or another reactive substrate and, with respect to a sub-class thereof, for the polymerisation of α-olefins and optionally conjugated dienes, with high activity at moderate tempera-tures. It also provides methods for obtaining polymers with very narrow molecular weight distribution by means of a living reaction. It also provides methods for making said metal complexes and novel intermediates involved in such methods. It further provides derivatives of said metal complexes which are suitable for covalent bonding to a carrier, the product of such covalent bonding being useful as a supported catalyst for heterogeneous catalytic reactions. It also provides a direct one-step synthesis of pyrrole, furan and thiophene compounds from diallyl compounds.

    专利号:WO-2006079916-A1
    优先权日:2005-01-26
    标 题 :Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation
    发明人:ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; RAHMAN HAYAT; SCHWEITZER BARBARA ANN; TENBRINK RUTH ELIZABETH
    权利人:PHARMACIA & UPJOHN CO LLC; ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; RAHMAN HAYAT; SCHWEITZER BARBARA ANN; TENBRINK RUTH ELIZABETH
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I): wherein A1, A2, A3, A4, A5, A6, A7, A8, X4, X6, R2, R4, R5, and R6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    专利号:CN-115485267-A
    优先权日:2020-05-06
    标题 :Synthesis of vinylcyclobutyl intermediates

    专利号:US-6936600-B2
    优先权日:1999-04-01
    标题:Sorbitol dehrydrogenase inhibitors
    发明人:CHU-MOYER MARGARET Y; MYLARI BANAVARA L; ZEMBROWSKI WILLIAM J
    权利人:PFIZER
    摘要:This invention is directed to sorbitol dehydrogenase inhibitory compounds of the formula I, n n nwherein R 1 , R 2 and R 3 are as defined in the specification. This invention is also directed to pharmaceutical compositions containing those compounds and methods of treating or preventing diabetic complications, particularly diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, diabetic macroangiopathy and diabetic cardiomyopathy by administering such compounds to a mammal suffering from diabetes and therefore at risk for developing such complications. This invention is also directed to pharmaceutical compositions comprising a combination of a compound of formula I of this invention with an aldose reductase inhibitor and to methods of treating or preventing diabetic complications therewith. This invention is also directed to pharmaceutical compositions comprising a combination of a compound of formula I of this invention with an NHE-1 inhibitor and to methods of treating cardiomyopathy and other heart-related problems therewith. This invention is also directed to certain intermediates used in the synthesis of the compounds of formula I and to processes for preparing those intermediates.

    专利号:CN-110831934-B
    优先权日:2017-05-12
    标 题:Method for the synthesis of N-acyl compounds without the use of organic solvents or acid chlorides

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.2165/00023210-200418010-00007
    摘要:Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM. Spotlight on lamotrigine in bipolar disorder. CNS Drugs. 2004;18(1):63–7. doi: 10.2165/00023210-200418010-00007.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知